157 related articles for article (PubMed ID: 27416001)
1. Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.
Gagne JJ; Han X; Hennessy S; Leonard CE; Chrischilles EA; Carnahan RM; Wang SV; Fuller C; Iyer A; Katcoff H; Woodworth TS; Archdeacon P; Meyer TE; Schneeweiss S; Toh S
Clin Pharmacol Ther; 2016 Nov; 100(5):558-564. PubMed ID: 27416001
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-An application to the known association between angiotensin-converting enzyme inhibitors and angioedema.
Panozzo CA; Welch EC; Woodworth TS; Huang TY; Her QL; Gagne JJ; Sun JW; Rogers C; Menzin TJ; Ehrmann M; Freitas KE; Haug NR; Toh S
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):829-838. PubMed ID: 29947045
[TBL] [Abstract][Full Text] [Related]
3. Application of the U.S. Food and Drug Administration's Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model-formatted National Health Insurance Research Database.
Lin FJ; Huang LY; Wang CC; Toh S
J Food Drug Anal; 2023 Dec; 31(4):772-781. PubMed ID: 38526825
[TBL] [Abstract][Full Text] [Related]
4. Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.
Toh S; Reichman ME; Houstoun M; Ding X; Fireman BH; Gravel E; Levenson M; Li L; Moyneur E; Shoaibi A; Zornberg G; Hennessy S
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1171-7. PubMed ID: 23878013
[TBL] [Abstract][Full Text] [Related]
5. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
6. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
[TBL] [Abstract][Full Text] [Related]
7. β-Blockers and angiotensin-converting enzyme inhibitors with sublingual immunotherapy: are risks related to individual product safety profile?
Smith DM; Coop CA; Freeman TM
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):401-406. PubMed ID: 32590508
[TBL] [Abstract][Full Text] [Related]
8. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
Schlienger RG; Korn JR; Wehler E; Lopez Leon S; Yeaw J
Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
[TBL] [Abstract][Full Text] [Related]
11. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.
Miller DR; Oliveria SA; Berlowitz DR; Fincke BG; Stang P; Lillienfeld DE
Hypertension; 2008 Jun; 51(6):1624-30. PubMed ID: 18413488
[TBL] [Abstract][Full Text] [Related]
12. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
Alharbi FF; Kholod AAV; Souverein PC; Meyboom RH; de Groot MCH; de Boer A; Klungel OH
Fundam Clin Pharmacol; 2017 Dec; 31(6):676-684. PubMed ID: 28767167
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema and Cough.
Hallberg P; Nagy J; Karawajczyk M; Nordang L; Islander G; Norling P; Johansson HE; Kämpe M; Hugosson S; Yue QY; Wadelius M
Ann Pharmacother; 2017 Apr; 51(4):293-300. PubMed ID: 27889699
[TBL] [Abstract][Full Text] [Related]
14. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
[No Abstract] [Full Text] [Related]
15. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.
Mott K; Graham DJ; Toh S; Gagne JJ; Levenson M; Ma Y; Reichman ME
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1023-32. PubMed ID: 27146123
[TBL] [Abstract][Full Text] [Related]
16. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
Win TS; Chaiyakunapruk N; Suwankesawong W; Dilokthornsakul P; Nathisuwan S
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):227-35. PubMed ID: 26342120
[TBL] [Abstract][Full Text] [Related]
17. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
[TBL] [Abstract][Full Text] [Related]
18. Safety assessment of niacin in the US Food and Drug Administration's mini-sentinel system.
Gagne JJ; Houstoun M; Reichman ME; Hampp C; Marshall JH; Toh S
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):30-37. PubMed ID: 29108128
[TBL] [Abstract][Full Text] [Related]
19. Is size the next big thing in epidemiology?
Toh S; Platt R
Epidemiology; 2013 May; 24(3):349-51. PubMed ID: 23549179
[No Abstract] [Full Text] [Related]
20. A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System.
Cocoros NM; Fuller CC; Adimadhyam S; Ball R; Brown JS; Dal Pan GJ; Kluberg SA; Lo Re V; Maro JC; Nguyen M; Orr R; Paraoan D; Perlin J; Poland RE; Driscoll MR; Sands K; Toh S; Yih WK; Platt R;
Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):827-837. PubMed ID: 33797815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
